Filing Flows › Core Laboratories (CLB) › Q2 2025
Core Laboratories (CLB) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 25, 2025
Core Laboratories (CLB) reported revenue of $130M for the second quarter 2025 (Q2 2025), -0.3% from a year earlier and +5% from the quarter before. Operating margin was 11.7%, net earnings $10.6M (8.2% of revenue).
Core Laboratories, Q2 2025: revenue $130M (-0.3% year over year), operating margin 11.7%, net earnings $10.6M, operating cash flow $13.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $130M | +5% | -0.3% |
| Operating profit | $15.3M | +246% | -4% |
| Net earnings | $10.6M | — | +18% |
| Operating cash flow | $13.9M | +109% | -19% |
| Free cash flow | $10.4M | — | — |
What changed
Revenue was $130.2M in Q2 2025, roughly flat year over year and up 5% from the previous quarter. Service was the largest line at 74% of revenue. Product lost $300K year over year (down 1%), 72% of the total change.
Operating profit was $15.3M, a 11.7% margin (down 0.5 points year over year). Total costs grew 0% against flat revenue. Net earnings were $10.6M, up 18% year over year. The effective tax rate was 15.2%.
Operating cash flow was $13.9M (down 19% year over year), 130% of net earnings. Non-cash charges added back $3.7M of depreciation and amortization and $538K of share-based compensation. Working capital and other items used $1.0M. After capital expenditures - operations ($3.5M), free cash flow as the company reports it was $10.4M.
Questions
What was Core Laboratories' revenue in the second quarter 2025?
Core Laboratories (CLB) reported revenue of $130M for the second quarter 2025 (Q2 2025), -0.3% from a year earlier and +5% from the quarter before.
Was Core Laboratories profitable in the second quarter 2025?
Operating profit was $15.3M (11.7% of revenue) and net earnings $10.6M.
Source: Core Laboratories 10-Q on SEC EDGAR.